2-Alkyl-4-carboxyalkyl-5-(3,3'-dimethyltriazeno)-imidazoles

Chemistry of carbon compounds – Miscellaneous organic carbon compounds – C-metal

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260141, 260248AS, 260309, 424226, A61I 2700, C07C11500

Patent

active

039975185

ABSTRACT:
Imidazoles of the formula: ##STR1## and their salts, wherein R.sub.1 is an optically substituted hydrocarbon, heterocyclic or thiol group; R.sub.2 is an amino or optionally substituted etherified hydroxyl group; R.sub.11 is a negative charge or alkyl group when R.sub.10 is N.sub.2 + or R.sub.11 is a hydrogen atom or alkyl group when R.sub.10 is N = N -- NR.sub.3 R.sub.4 where R.sub.3 is methyl or .beta.-chloroethyl and R.sub.4 is optionally substituted hydrocarbon. When R.sub.10 is N.sub.2 + the compounds are useful as intermediates in the synthesis of compounds wherein R.sub.10 is N=N-- NR.sub.3 R.sub.4 these latter compounds possessing anti-tumor and/or anti-microbial activity.

REFERENCES:
patent: 3649613 (1972-03-01), Krauth et al.
Shealy et al (I), J. Org. Chem., vol. 27, pp. 2150-2154 (1962).
Shealy et al (II), J. Med. Chem., vol. 9, pp. 34-38 (1966).
Shealy et al (III), J. Pharm. Sciences, vol. 56, pp. 147-148 (1967).
Shealy et al (IV), Nature, vol. 210, p. 208 (1966).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-Alkyl-4-carboxyalkyl-5-(3,3'-dimethyltriazeno)-imidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-Alkyl-4-carboxyalkyl-5-(3,3'-dimethyltriazeno)-imidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-Alkyl-4-carboxyalkyl-5-(3,3'-dimethyltriazeno)-imidazoles will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1344059

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.